INNOSELF Trademark

Trademark Overview


On Friday, September 25, 2020, a trademark application was filed for INNOSELF with the United States Patent and Trademark Office. The USPTO has given the INNOSELF trademark a serial number of 79297737. The federal status of this trademark filing is REGISTERED as of Tuesday, November 23, 2021. This trademark is owned by TMD LAB Co. Ltd. The INNOSELF trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for treating chronic renal failure, angina, myocardial infarction, organ transplant and reconstruction, nasolacrimal duct obstruction, dry eye syndrome, glaucoma, rhinoplasty, breast implant, biliary duct cancer, dental implant, denture, knee arthritis, hip arthritis, shoulder arthritis; medical instruments for treating dry eye syndrome, glaucoma; medical apparatus for treating dry eye syndrome, glaucoma; stents; medical stents; biocompatible coated stents; implantable urethral stents; self-expanding vascular stents; cardiovascular instruments, namely, medical instruments for treating or diagnosing angina, myocardial infarction; medical devices, namely, intravascular implants comprised of artificial material; prosthetic tissues for parietal/visceral and vascular use; tubes for perfusion for treating nasolacrimal duct obstruction, glaucoma; tubes for surgical purposes for treating nasolacrimal duct obstruction, glaucoma; tubes for medical purposes for t...
innoself

General Information


Serial Number79297737
Word MarkINNOSELF
Filing DateFriday, September 25, 2020
Status700 - REGISTERED
Status DateTuesday, November 23, 2021
Registration Number6564701
Registration DateTuesday, November 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements


Pseudo MarkINNO SELF
Goods and ServicesMedical apparatus and instruments for treating chronic renal failure, angina, myocardial infarction, organ transplant and reconstruction, nasolacrimal duct obstruction, dry eye syndrome, glaucoma, rhinoplasty, breast implant, biliary duct cancer, dental implant, denture, knee arthritis, hip arthritis, shoulder arthritis; medical instruments for treating dry eye syndrome, glaucoma; medical apparatus for treating dry eye syndrome, glaucoma; stents; medical stents; biocompatible coated stents; implantable urethral stents; self-expanding vascular stents; cardiovascular instruments, namely, medical instruments for treating or diagnosing angina, myocardial infarction; medical devices, namely, intravascular implants comprised of artificial material; prosthetic tissues for parietal/visceral and vascular use; tubes for perfusion for treating nasolacrimal duct obstruction, glaucoma; tubes for surgical purposes for treating nasolacrimal duct obstruction, glaucoma; tubes for medical purposes for treating nasolacrimal duct obstruction, glaucoma; medical devices, namely, expandable braids for insertion in bile ducts for treating stenosis; medical devices, namely, expandable braids for insertion in oesophagus for the treatment of stenosis; medical devices, namely, expandable braids for insertion in tubular organs of the body for the treatment of stenosis; medical devices, namely, expandable braids for insertion in blood vessels for treating stenosis; catheters; tubing for use with catheters

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, November 16, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTMD LAB Co. Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameTMD LAB Co. Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameTMD LAB Co. Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, June 6, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 12, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 12, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 23, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Sunday, September 5, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 18, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 2, 2021ASSIGNED TO LIE
Monday, August 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 15, 2021REFUSAL PROCESSED BY IB
Wednesday, February 24, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 24, 2021REFUSAL PROCESSED BY MPU
Saturday, February 20, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 19, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 17, 2021ASSIGNED TO EXAMINER
Friday, November 20, 2020APPLICATION FILING RECEIPT MAILED
Monday, November 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 12, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB